UK Watchdog Group Accuses Pfizer, Flynn Pharma of Price Gouging on Epilepsy Drug

A United Kingdom watchdog organization has accused Pfizer and Flynn Pharma of violating antitrust rules and overcharging that country’s National Health Services for anti-epilepsy treatments. The Competition and Markets Authority (CMA) in the U.K. accused the companies of exploiting a loophole in order to charge higher prices for phenytoin sodium capsules.

Read the source article at biospace.com
2021-08-05 04:00:00